Public Reporting Information

Adirondacks ACO is governed by a Board of Managers composed of a diverse group of participants with  representation from regional providers, hospitals and a Medicare beneficiary. Adirondacks ACO is developing a Clinical Advisory Board and five operational Advisory Committees that focus on Quality and Care Management Programs, Beneficiary Engagement, Finance, participant network and Informatics.

ACO Name and Location
Adirondacks ACO, LLC
75 Beekman Street
Plattsburgh, NY 12901

ACO Primary Contact
Karen Ashline (518) 314-3663
kashline@cvph.org

Types of ACO participants, or combinations of participants, that formed the ACO: The Adirondacks ACO is owned by The University of Vermont Health Network – Champlain Valley Physicians Hospital and Hudson Headwaters Health Network. The Adirondacks ACO includes, ACO professionals in a group practice arrangement; a network of individual practices of ACO professionals; a hospital employing ACO professionals; a critical access hospital (CAH) billing under Method II; and a federally qualified health center (FQHC).

ACO Participants

Adirondack Internal Medicine and Pediatrics
Adirondack Medical Center DBA Adirondack Health
Adirondack Medical Practice, LLC
Adirondack Primary Care
Adirondack Pulmonary & Sleep Medicine
Kristin Ambler, MD
BayWood Surgical
Debra Clark, MD
Glens Falls Hospital, Inc.
Stephen Hausrath, MD
Hudson Headwaters Health Network ( HHHN)
Irongate Family Practice Associates, PLLC
Lake City Primary Care
Medical Associates of Saranac Lake, P.C.
William Pelton, MD
Peru Family Medicine, PLLC
Plattsburgh Medical Care, PLLC
Viqar Qudsi, MD
Russell E Rider, MD
University of Vermont Health Network – Alice Hyde Medical Center
University of Vermont Health Network – Champlain Valley Physicians Hospital
University of Vermont Health Network – Elizabethtown Community Hospital
University of Vermont Medical Group – New York , PLLC

ACO Governing Body
Board of Managers

  • John Rugge, MD (Chair) - Voting Member, ACO Participant, CEO, Hudson Headwaters Health Network
  • Sylvia Getman (Vice Chair) - Voting Member, ACO Participant, Adirondack Health
  • Kris Ambler, MD – Voting Member, ACO Participant, Kris Ambler MD
  • David Beguin, MD - Voting Member, ACO Participant, Primary Care Health Partners – Adirondack, LLC
  • Elizabeth Buck, MD – Voting Member, ACO Participant, Adirondack Internal Medicine and Pediatrics
  • John Brumsted, MD – Voting Member, President and CEO, University of Vermont Health Network
  • Paul Filion, MD -  Voting Member, ACO Participant, Irongate Family Practice Associates
  • Martin Mannix – Voting Member, Medicare Beneficiary
  • Tracy Mills - Voting Member, ACO Participant, Glens Falls Hospital
  • Todd Moore – Voting Member, University of Vermont Health Network
  • Stephens Mundy  – Voting Member, ACO Participant, President and CEO, University of Vermont Health Network – Champlain Valley Physicians Hospital
  • David Slingerland, MD – Voting Member, ACO Participant, Hudson Headwaters Health Network
  • Chris Tournier - Voting Member, ACO Participant, Hudson Headwaters Health Network
  • Dianne Shugrue - Voting Member, ACO Participant, CEO Glens Falls Hospital
  • Margaret Vosburgh -  Voting Member, Adirondack Health Institute

Associated Committees and Committee Leadership
Executive Committee -  John Rugge, MD, Chair
Finance Committee  – Chris Tournier, Chair
Population Health - David Beguin, MD, Chair
Data Governance – Kevin Gallagher, MD, Chair
Beneficiary Engagement Committee – Crystal Carter, Chair

Compliance Officer
Kirsten Pope, CPA – (518) 562-7416 or via email at kpope@cvph.org.  You may file an anonymous report on the Compliance Hotline at  (877) 518-3579 or file a report online by visiting this page and clicking on the Adirondacks ACO logo.

 

Shared Savings and Losses: Amount of Shared Savings/Losses

  • Agreement period beginning 2014, Performance Year 2014: $ 0.00
  • Agreement period beginning 2014, Performance Year 2015: $ 0.00

 

How Shared Savings are Distributed

  • Central operation costs of the ACO: 25%
  • Proportion of Distribution to ACO Participants:
    • Primary Care Clinicians: 50%
    • Hospitals: 40%
    • Specialty Clinicians: 10%

2015 Quality Performance Results

Measure number Measure Name 2015 reporting period
ACO
performance
Mean
performance
ACO-1 CAHPS: Getting Timely Care, Appointments, and Information 84.20 80.61
ACO-2 CAHPS: How Well Your Providers Communicate 93.66 92.65
ACO-3 CAHPS: Patients’ Rating of Provider 92.20 91.94
ACO-4 CAHPS: Access to Specialists 86.06 83.61
ACO-5 CAHPS: Health Promotion and Education 63.43 59.06
ACO-6 CAHPS: Shared Decision Making 76.18 75.17
ACO-7 CAHPS: Health Status/Functional Status 72.18 72.30
ACO-34 CAHPS: Stewardship of Patient Resources* 24.82 26.87
ACO-8 Risk Standardized, All Condition Readmission 14.51 14.86
ACO-35 Skilled Nursing Facility 30-Day All-Cause Readmission Measure (SNFRM)* Readmission 18.40 18.07
ACO-36 All-Cause Unplanned Admissions for Patients with Diabetes* 54.29 54.60
ACO-37 All-Cause Unplanned Admissions for Patients with Heart Failure* 77.15 76.96
ACO-38 All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions 65.87 62.92
ACO-9 Ambulatory Sensitive Condition Admissions: Chronic Obstructive Pulmonary Disease or Asthma in Older Adults (AHRQ Prevention Quality Indicator (PQI) #5) 1.00 1.11
ACO-10 Ambulatory Sensitive Conditions Admissions: Heart Failure (AHRQ Prevention Quality Indicator (PQI) #8) 1.00 1.04
ACO-11 Percent of Primary Care Physicians who Successfully Meet Meaningful Use Requirements 92.17% 80.14%
ACO-39 Documentation of Current Medications in the Medical Record* 89.31% 84.07%
ACO-13 Falls: Screening for Future Fall Risk 68.93% 56.46%
ACO-14 Preventive Care and Screening: Influenza Immunization 72.73% 62.03%
ACO-15 Pneumonia Vaccination Status for Older Adults 80.81% 63.73%
ACO-16 Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-up 74.18% 71.15%
ACO-17 Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention 95.48% 90.16%
ACO-18 Preventive Care and Screening: Screening for Clinical Depression and Follow-up Plan 68.11% 45.25%
ACO-19 Colorectal Cancer Screening 70.63% 60.06%
ACO-20 Breast Cancer Screening 74.37% 65.67%
ACO-21 Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented 71.92% 70.04%
ACO-40 Depression Remission at Twelve Months* N/A N/A
ACO-27 Diabetes Mellitus: Hemoglobin A1c Poor Control 15.07% 20.38%
ACO-41 Diabetes: Eye Exam* 61.99% 41.05%
ACO-28 Hypertension: Controlling High Blood Pressure 71.40% 69.62%
ACO-30 Ischemic Vascular Disease: Use of Aspirin or Another Antithrombotic 87.85% 83.82%
ACO-31 Heart Failure: Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD) 80.79% 87.22%
ACO-33 Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy – for patients with CAD and Diabetes or Left Ventricular Systolic Dysfunction (LVEF<40%) 75.89% 77.73%
CAHPS = Consumer Assessment of Healthcare Providers and Systems, PQI = Prevention Quality Indicator, LVSD = left ventricular systolic dysfunction, ACE = angiotensin-converting enzyme, ARB = angiotensin receptor blocker, CAD = coronary artery disease.*= Measure required beginning Reporting Year 2015.N/A= Reporting on the depression remission measure is not required for 2015, as indicated by N/A